Biotech Analysts, along with MedaCorp Specialist Federico Cappuzzo1 discuss Nuvalent’s NVL-655 ALK+NSCLC Data on an Analyst/Industry conference call to be held on September 28 at 2:30 pm.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NUVL:
- Leerink biotech analysts hold an analyst/industry conference call
- Nuvalent initiated with a Buy at Stifel
- Nuvalent, Olema, Oric added to ‘Catalyst Watch List’ at JPMorgan
- Nuvalent initiates Phase 2 portion of ARROS-1 trial
- Nuvalent Highlights Pipeline Progress and Reports Second Quarter 2023 Financial Results